Predictors of early neurologic deterioration (END) following stroke thrombectomy
- PMID: 35584910
- DOI: 10.1136/neurintsurg-2022-018844
Predictors of early neurologic deterioration (END) following stroke thrombectomy
Abstract
Background: Early neurologic deterioration (END) following ischemic stroke is a serious event and is associated with poor outcomes. However, the incidence and predictors of END after stroke thrombectomy for emergent large vessel occlusion are largely unknown.
Methods: The baseline characteristics of patients enrolled in the COMPASS trial (NCT02466893) were analyzed. The primary outcome was worsening of ≥4 National Institutes of Health Stroke Scale (NIHSS) points 24 hours post thrombectomy (4+ END24) and the secondary outcome was deterioration of ≥2 points (2+ END24).
Results: Among 270 patients, 27 (10%) developed 4+ END24 and 42 (16%) had 2+ END24. Those with 4+ END24 were older (76.4±12.9 vs 70.9±12.9 years; p=0.04), had a higher prevalence of hypertension (96% vs 69%; p=0.003), diabetes (41% vs 27%; p=0.13) and higher pretreatment systolic blood pressure (SBP) (170.4±32.6 vs 157.6±28.1 mmHg; p=0.03). More 4+ END24 patients had failed reperfusion: Thrombolysis in Cerebral Infarction ≤2a (26% vs 8%; p=0.003). In unadjusted analysis, older patients and those with hypertension, diabetes, elevated SBP and failed reperfusion had higher odds of 4+ END24. In adjusted analysis, age increase by 5 years led to an increase in 4+ END24 of 28%, diabetes increased odds of 2.6 and failed reperfusion increased odds of 4.5. In the multivariable analysis for the secondary outcome, age (OR 1.33; 95% CI 1.109 to 1.593), diabetes (OR 2.7; 95% CI 1.247 to 5.764) and failed reperfusion (OR 7.2; 95% CI 0.055 to 0.349) were also significant predictors of 2+ END24.
Conclusions: Older patients with acute ischemic stroke who have a history of diabetes or hypertension, with elevated pretreatment SBP and failed reperfusion are at a higher risk of END following stroke thrombectomy for emergent large vessel occlusion.
Keywords: Stroke; Thrombectomy.
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None
Similar articles
-
Predictors and outcome of early neurological deterioration after endovascular thrombectomy: a secondary analysis of the DIRECT-MT trial.J Neurointerv Surg. 2023 Sep;15(e1):e9-e16. doi: 10.1136/neurintsurg-2022-018976. Epub 2022 Jun 10. J Neurointerv Surg. 2023. PMID: 35688618
-
Predictors of mortality in acute ischemic stroke treated with endovascular thrombectomy despite successful reperfusion: subgroup analysis of a multicentre randomised clinical trial.BMJ Open. 2022 Mar 1;12(3):e053765. doi: 10.1136/bmjopen-2021-053765. BMJ Open. 2022. PMID: 35232782 Free PMC article. Clinical Trial.
-
An Initial High National Institutes of Health Stroke Scale Score and Any Intracranial Hemorrhage Are Independent Factors for a Poor Outcome in Nonagenarians Treated with Thrombectomy for Acute Large Vessel Occlusion: The Tokyo/Tama-REgistry of Acute Endovascular Thrombectomy (TREAT) Study.World Neurosurg. 2022 Sep;165:e325-e330. doi: 10.1016/j.wneu.2022.06.038. Epub 2022 Jun 16. World Neurosurg. 2022. PMID: 35717017
-
Predictors of Early Neurological Deterioration Occurring within 24 h in Acute Ischemic Stroke following Reperfusion Therapy: A Systematic Review and Meta-Analysis.J Integr Neurosci. 2023 Mar 23;22(2):52. doi: 10.31083/j.jin2202052. J Integr Neurosci. 2023. PMID: 36992598
-
[Evidence and Patient Selection for Endovascular Reperfusion Therapy for Acute Ischemic Stroke:A Narrative Review].No Shinkei Geka. 2023 Mar;51(2):314-327. doi: 10.11477/mf.1436204747. No Shinkei Geka. 2023. PMID: 37055053 Review. Japanese.
Cited by
-
Early neurological deterioration in patients with acute ischemic stroke is linked to unfavorable cerebral venous outflow.Eur Stroke J. 2024 Mar;9(1):162-171. doi: 10.1177/23969873231208277. Epub 2023 Dec 9. Eur Stroke J. 2024. PMID: 38069665 Free PMC article.
-
Interpretable Machine Learning Model Predicting Early Neurological Deterioration in Ischemic Stroke Patients Treated with Mechanical Thrombectomy: A Retrospective Study.Brain Sci. 2023 Mar 26;13(4):557. doi: 10.3390/brainsci13040557. Brain Sci. 2023. PMID: 37190522 Free PMC article.
-
Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial.CNS Drugs. 2025 Feb;39(2):197-208. doi: 10.1007/s40263-024-01145-5. Epub 2025 Jan 5. CNS Drugs. 2025. PMID: 39755915 Clinical Trial.
-
Association of atherogenic index of plasma with early-onset post-stroke depression: a prospective study.Front Psychiatry. 2025 Jul 25;16:1563289. doi: 10.3389/fpsyt.2025.1563289. eCollection 2025. Front Psychiatry. 2025. PMID: 40787681 Free PMC article.
-
Accurate forecasting in acute ischemic stroke: innovative nomogram models for early neurological deterioration and 90-day prognosis outcomes following intravenous thrombolysis.Eur J Med Res. 2025 Jul 25;30(1):671. doi: 10.1186/s40001-025-02869-w. Eur J Med Res. 2025. PMID: 40708031 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical